Donald Anthony is a Rheumatology/Immunology physician affiliated with MetroHealth. OpenAlex indexes 171 publications with 5,408 citations (h-index 41); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
41.7%Folate Analog Metabolic Inhibitor21.4%Methotrexate100%Part D<11 patientsAntirheumatic Agent7.1%Leflunomide100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
31.5%Corticosteroid21.4%Prednisone100%Part D≥12 patientsAntidiarrheal microorganisms10.1%Folic Acid100%Part D<11 patientsMusculoskeletal
17.9%Nonsteroidal Anti-inflammatory Drug10.7%Diclofenac Sodium100%Part D<11 patientsAlkaloid7.1%Colchicine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
11 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
- Role of NK cells in control of HCV infection associated hepatocellular carcinoma
Louis Stokes Cleveland Va Medical Center
FY2026I01BX001894 - Role of NK cells in control of HCV infection associated hepatocellular carcinoma
Louis Stokes Cleveland Va Medical Center
FY2025I01BX001894 - Role of NK cells in control of HCV infection associated hepatocellular carcinoma
Louis Stokes Cleveland Va Medical Center
FY2024I01BX001894
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Alfred Connors, MD
MetroHealth
Mark Dunlap, MD
MetroHealth
Michelle Hecker, MD
MetroHealth
Ashish Aneja, MD
MetroHealth
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”